BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17526976)

  • 1. Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China.
    Zhu WL; Shan YD; Guo JX; Wei JP; Yang XC; Li TD; Jia SQ; He Q; Chen JZ; Wu ZG; Li ZQ; You K
    Circ J; 2007 Jun; 71(6):826-33. PubMed ID: 17526976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
    Nordlander R; Walter M
    Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
    Yasky J; Ontanilla E; Koch JE
    Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
    Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
    Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
    Glasser SP
    Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
    Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
    Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris.
    Raubach KH; Vlahov V; Wolter K; Bussmann WD
    Clin Cardiol; 1997 May; 20(5):483-8. PubMed ID: 9134282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.
    Di Somma S; Liguori V; Petitto M; Carotenuto A; Bokor D; de Divitiis O; de Divitiis M
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):119-23. PubMed ID: 8485067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dosage. 5-ISMN headache study group.
    Cleophas TJ; Niemeyer MC; van der Wall EE; van der Meulen J
    Angiology; 1996 Jul; 47(7):679-85. PubMed ID: 8686962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
    Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade.
    Uusitalo A; Keyriläinen O; Härkönen R; Rautio P; Rehnqvist N; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G
    Acta Med Scand; 1988; 223(3):219-25. PubMed ID: 2895564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM; Curry PV; Bailey AE; Steare SE
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
    Akhras F; Chambers J; Jefferies S; Jackson G
    Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.
    Svendsen JH; Klarlund K; Aldershvile J; Waldorff S
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):320-3. PubMed ID: 2468964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.